Graphical Abstract.pdf (166.32 kB)
Evolocumab-based LDL-C management in high and very high cardiovascular risk patients in German clinical practice: the HEYMANS study
media
posted on 2023-12-19, 15:35 authored by Adis journals on behalf of, Michael Lehrke, Anja Vogt, Volker Schettler, Matthias Girndt, Uwe Fraass, Anja Tabbert-Zitzler, Ian Bridges, Nafeesa N. Dhalwani, Kausik K. Ray
The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).
